Aspera Biomedicines Inc., a biotechnology company developing first-in-class therapies targeting cancer stem cells, announced that its second ADAR1p150 protein crystallization experiment has…
Galvanize Therapeutics, Inc., a commercial-stage medical technology company pioneering pulsed electric field (PEF) therapies for oncology and chronic lung disease, today announced that it received U…
BD (Becton, Dickinson and Company) a leading global medical technology company, today announced that Peter Menziuso has been named executive vice president and president, BD Interventional, effective…
Ferring Pharmaceuticals announced a new real-world case series demonstrating that re-induction with ADSTILADRIN® (nadofaragene firadenovec-vncg) resulted in complete responses (CR) in approximately…
The concept of biohacking often brings to mind performance tracking and high-tech optimization – but at its core, it's a mindset grounded in understanding how the body functions and supporting it to…
AstraZeneca and Daiichi Sankyo’s ENHERTU® (fam-trastuzumab deruxtecan-nxki) has been approved by the US Food and Drug Administration (FDA) for both the neoadjuvant and adjuvant treatment of patients…
High-level results from a planned interim analysis of the VOLGA Phase III trial showed perioperative treatment with IMFINZI® (durvalumab) in combination with neoadjuvant enfortumab vedotin (EV…
Two nationally recognized leaders in neurocritical care nursing will join NeurOptics at the upcoming American Association of Critical Care Nurses National Teaching Institute & Critical Care…
Nutraceutical ingredients innovator SUANNUTRA USA announces it has inked a distribution agreement with Spanish biotech company Fitoplancton Marino, S.L. to provide TetraSOD® for the North American…
As chronic conditions tied to metabolic health continue to rise across the United States, MinuteClinic®, the medical clinic inside select CVS Pharmacy® locations, is highlighting its clinically…
You are receiving this email because you have visited our site or asked us about the regular newsletter. To make sure our messages get to your Inbox (and not your bulk or SPAM or junk folders), please add
info@pharmaceutical-era.com to your contacts!
Aspera Biomedicines launched its second ADAR1p150 crystallization to the ISS aboard SpaceX CRS-34
Galvanize Therapeutics receives FDA clearance for the Aliya EX Generator, expanding its Aliya Pulsed Electric Field portfolio
Peter Menziuso named EVP and President of BD Interventional
A new real-world case series examines re-induction with ADSTILADRIN in clinical practice
Biohack skin longevity with Futurecode Booster
ENHERTU received U.S. approval for two new indications in HER2-positive early breast cancer.
IMFINZI plus neoadjuvant EV improved survival outcomes in muscle-invasive bladder cancer in the Phase III VOLGA trial
Neurocritical care leaders will discuss NPi pupillometry in NeurOptics sessions at AACN NTI 2026.
SUANNUTRA USA secures U.S. distribution rights for TetraSOD.
MinuteClinic highlights improved access and outcomes through its clinically supervised weight-loss program
